Skip header and navigation

Refine By

22 records – page 1 of 3.

smallpox vaccine (glycerinated)

https://mhc.andornot.com/en/permalink/artifact15280
Dates
1978
1979
circa 1978 – 1979
Category
Vaccination
Classification
Vaccination
Pharmacy, Infectious Diseases
Accession Number
012037001 a-e
Description
Small cylindrical white plastic smallpox vaccine tube (a) with cylindrical black metal screw cap (b) containing one small transparent cylindrical glass vial of yellow glycerinated smallpox vaccine (c), one small transparent cylindrical glass vial containing grey metal scarification needle (d) and s…
  5 images  
Accession Number
012037001 a-e
Category
Vaccination
Classification
Vaccination
Pharmacy, Infectious Diseases
MeSH Heading
Vaccines
Vaccination
Vaccination -- instrumentation
Smallpox Vaccine
Smallpox Virus
Infection
Description
Small cylindrical white plastic smallpox vaccine tube (a) with cylindrical black metal screw cap (b) containing one small transparent cylindrical glass vial of yellow glycerinated smallpox vaccine (c), one small transparent cylindrical glass vial containing grey metal scarification needle (d) and small pyriform black rubber bulb (e); tube has circular push up at base with manufacturer information embossed, product information printed on sides in black ink, and cylindrical finish with external continuous thread; cap has flat top, vertical indents in sides, rolled bottom edge, and brass coloured interior with circular white paper insert at top; both vials are thin and have round ends; bulb is hollow with circular hole at both ends.
Number Of Parts
5
Part Names
a – tube – Length 8.6 cm Diameter 1.4 cm
b – cap – Length 0.8 cm Diameter 1.6 cm
c – vaccine – Length 6.4 cm Diameter 0.1 cm
d – needle – Length 6.4 cm Diameter 0.2 cm
e – bulb – Length 1.2 cm Diameter 0.8 cm
Provenance
Belonged to donor, found at estate yard sale; previous owner was a nurse.
Maker
Connaught Laboratories Limited
Site Made (City)
Toronto
Site Made (State)
Ontario
Site Made (Country)
Canada
Dates
1978
1979
circa 1978 – 1979
Date Remarks
Based on expiration date printed on container tube
Material
plastic: white
metal: black, brass, grey
paper: white
glass: clear
rubber: black
ink: black
Inscriptions
Printed on exterior of tube: “SMALLPOX VACCINE (GLYCERINATED) // Freon Purified // STORE BELOW 5ºC (41ºF.) // Directions for use: See enclosed leaflet // Can. Lic. No. 3 Code: PEACH Pres: Phenol 0.4% // CONNAUGHT LABORATORIES LIMITED // Willowdale Toronto, Canada // LOT 796-15 // EXP. DATE: APR 25 79 // DIN 075027 // 1 TUBE // 1 TUBE”; embossed on base of tube: “LERMER // GARWOOD, N. J.”
Permanent Location
Storage Room 0010
0010-A3-7
Unit Of Measure
centimeters
Condition Remarks
Minor abrasion near top edge of cap; minor scratching all over exterior of tube
Copy Type
original
Reference Types
Article (online)
Website
Reference Comments
Rutty, Christopher J. “Origins: From the Connaught Fund & Back to Connaught Laboratories.” Connaught Fund, The Connaught Fund at the University of Toronto, 2019. Accessed 3 August 2019.
Tesini, Brenda L. “Smallpox.” Merck Manual, Merck Sharp & Dohme Corp, 2019. Accessed 3 August 2019.
Research Facts
Smallpox was a highly infectious disease with an extremely high mortality rate; it was caused by the variola virus and spread through the air from person to person; symptoms included severe abdominal pain, fever, and rash; the smallpox vaccine was developed in 1796 by Edward Jenner and is considered the first vaccine ever developed; smallpox is considered eradicated and no cases have been reported since 1977.
Connaught Laboratories was established in 1914 at the University of Toronto as the Antitoxin Laboratory in the Department of Hygiene; it was established in part due to increased awareness and agency in treatment and prevention of infectious diseases within the public health context of Canadian society; Dr. John Gerald FitzGerald was the driving force behind the establishment of the laboratory which initially focused on producing diphtheria antitoxin; Connaught Laboratories maintained a non-commercial mandate for much of the twentieth century and expanded significantly following the discovery of insulin and through combating the spread of infectious diseases during and after the World Wars; Connaught Laboratories was an industry leader in the production of a variety of vaccines including typhus, smallpox, and polio, as well as other medical products including penicillin and insulin; eventually became privately owned in 1986 under the Mulroney government.
Images
Less detail

Pertussis Antigen vials

https://mhc.andornot.com/en/permalink/artifact8768
Dates
1938
circa 1938
Collection
University Health Network - Academy of Medicine Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectiious Diseases
Vaccination
Accession Number
1997.2.7
Description
A cardboard box wrapped around with printed labels describing contents and usage; contains vials of pertussis (whooping cough) antigen; unopened.
  1 image  
Accession Number
1997.2.7
Collection
University Health Network - Academy of Medicine Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectiious Diseases
Vaccination
MeSH Heading
Drugs
Antigens
Pertussis Vaccine
Vaccination
Immunization
Whooping Cough -- drug therapy
MM= Drug Packaging -- container -- vial
Description
A cardboard box wrapped around with printed labels describing contents and usage; contains vials of pertussis (whooping cough) antigen; unopened.
Number Of Parts
1
Provenance
Acquired from the Academy of Medicine; source: Dr. H.B. Rundle (1911-1997) via Mr. Howard Rundle.
Maker
Lederle Laboratories Inc.
Site Made (City)
New York
Site Made (State)
New York
Site Made (Country)
United States of America
Dates
1938
circa 1938
Material
cardboard
paper: off-white
ink: black
glass
liquid
Inscriptions
Printed on box: "3 vials 2 cc. size // PERTUSSIS ANTIGEN // (DETOXIFIED) // Lederle (in cursive script) // BACTERIAL ANTIGEN MADE FROM // Pertussis Bacillus"
Permanent Location
Storage Room 0010
0010-A2-4 Row F
Temporary Location
On display: "Vaccines and Immunization: Epidemics, Prevention, and Canadian Innovation"; Museum of Health Care, Nov. 28, 2013.
Dimension Notes
Length 5.7 cm x Width 4.0 cm x Depth 2.4 cm
Condition Remarks
Label intact; stained and discoloured.
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #UHN
Images
Less detail

glycerated vaccine virus

https://mhc.andornot.com/en/permalink/artifact14730
Dates
1935
1939
circa 1935-1939
Collection
University Health Network - Academy of Medicine Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
Accession Number
1997.3.2 a-b
Description
Empty rectangular cream cardboard box.
Accession Number
1997.3.2 a-b
Collection
University Health Network - Academy of Medicine Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
MeSH Heading
Vaccination
Smallpox Virus
Immunization
Public Health
Description
Empty rectangular cream cardboard box.
Number Of Parts
1
Provenance
Acquired from the Academy of Medicine; source: Penny Ecclestone; belonged to her father, Dr. Leland W. C. Sturgeon (1905-78).
Maker
Connaught Laboratories
Site Made (City)
Toronto
Site Made (State)
Ontario
Site Made (Country)
Canada
Dates
1935
1939
circa 1935-1939
Material
cardboard: cream
ink: black, red
Inscriptions
On box: “2 TUBES // VACCINE VIRUS, GLYCERINATED // Canadian // Licence // No. 3 // Connaught Laboratories, University of Toronto // NOT TO BE SOLD // Distributed FREE by the Department of Health, Ontario //KEEP IN REFRIGERATOR // If kept in a temperature below 5’C (41’F), this vaccine will retains its // potency until AUG 27 1939 Lot 380-2”
Permanent Location
Storage Room 0010
0010-A3-4 Row A Box 2
Length
9.0 cm
Width
1.2 cm
Depth
1.2 cm
Unit Of Measure
centimeters
Copy Type
original
Research Facts
Dr. Sturgeon graduated from the University of Toronto Faculty of Medicine in 1930; he was in private practice from 1931 to 1940, at which time he joined the RCAF as a medical officer; in 1945, he went into Public Health in Welland, Ont., where he was Medical Officer of Health until his retirement in 1973.
Less detail
Dates
1910
circa 1910
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
Accession Number
000001082
Description
Cylindrical wooden container with lid, wrapped with a paper label around circumference; overlaid with another, smaller paper label; contains a tube of rolled paper that surrounds nine sealed (glass?) tubes of liquid.
  2 images  
Accession Number
000001082
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
MeSH Heading
Vaccines
Vaccination -- instrumentation
MM= Drugs -- vaccines -- container
Description
Cylindrical wooden container with lid, wrapped with a paper label around circumference; overlaid with another, smaller paper label; contains a tube of rolled paper that surrounds nine sealed (glass?) tubes of liquid.
Number Of Parts
1
Provenance
Collected by Parke-Davis
Maker
Parke, Davis
Dates
1910
circa 1910
Date Remarks
Label gives Sept. 9, 1910 as a "best before" date.
Material
glass: amber
paper: red; yellow; black
wood: light brown
Inscriptions
"TEN TUBES // VACCINE (GLYCERINATED) // WITH SCARIFYING NEEDLE // PHYSIOLOGICALLY AND BACTERIOLOGICALLY TESTED // CAUTION--Keep the package below [illeg.] 0°F. if possible; summer tem- // perature will rapidly weaken vaccine. // We would recommend that this product be returned after SEPT - 9 - 1910 [stamped] // to be replaced with fresh product. This vaccine will, however, retain its potency for // a much longer period, if kept under proper conditions. // Note directions enclosed before using the vaccine. // LICENSE No. 1, issued to Parke, Davis by the Secretary of the Treasury, // U.S.A., under provision of Act approved July 1, 1902. // 014472 - P // PREPARED IN THE BIOLOGICAL LABORATORIES OF // PARKE, DAVIS & CO. DETROIT, MICH. U.S.A. // [illeg.] N LABORATOR [illeg.] WALKERVILLE, Ontario. // [illeg.] AL. Quebec. [illeg.] NOON, England."
Permanent Location
Storage Room 0010
0010-A
Temporary Location
On exhibit at City of Ottawa - Public Health L-2016-3 14 Mar 2016 – 31 Dec 2018
Dimension Notes
Length 9.7 cm x Diam. 1.4 cm
Condition Remarks
Wooden container is in good shape; labels and yellowed, torn, abraded, and wrinkled and are missing pieces
Copy Type
Original
Exhibit History
On exhibit, "Potions, Pills, and Prescriptions," Museum of Health Care, May 1, 2000.
Images
Less detail

measles vaccine kit

https://mhc.andornot.com/en/permalink/artifact4044
Dates
1968
circa 1968
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001249 a-g
Description
A styrofoam container (a) consisting of two moulded pieces of styrofoam held together by the label; inside are five cylindrical glass ampoules (b-f) with icicle-shaped melted glass seals containing the vaccine and one glass vial (g) stopped with a rubber stopper and sealed with a metal ring around …
  4 images  
Accession Number
000001249 a-g
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Measles -- prevention & control
Measles Vaccine
Vaccination
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- ampoule
Description
A styrofoam container (a) consisting of two moulded pieces of styrofoam held together by the label; inside are five cylindrical glass ampoules (b-f) with icicle-shaped melted glass seals containing the vaccine and one glass vial (g) stopped with a rubber stopper and sealed with a metal ring around the lip containing a diluent.
Number Of Parts
7
Part Names
a - box - Size: Length 13.9 cm x Width 8.3 cm x Depth 3.0 cm
b - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
c - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
d - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
e - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
f - ampoule - Size: Length 5.8 cm x Diam. 1.1 cm
g - vial - Size: Length 4.1 cm x Diam. 2.1 cm
Provenance
Collected by Parke-Davis
Maker
Philips Roxane, Inc.
Site Made (City)
St. Joseph
Site Made (State)
Missouri
Site Made (Country)
United States of America
Dates
1968
circa 1968
Date Remarks
Earliest expiry date
Material
styrofoam: white
paper: white; blue; black
glass: clear; blue
rubber: yellow
metal: silver
Inscriptions
(a) Top: "5 DOSES Bio. 49 // MEASLES VIRUS VACCINE, // LIVE, ATTENUATED // C // Contains 5 one-dose ampoules of attenuated Edmonston strain vaccine grown on // tissue cultures of canine renal cells and one 4.5 cc. vial of diluent for preparing solu- // tion for injection. Diluent contains 0.05% methylparaben and 0.005% propylparaben // as preservatives. // Prepare solution for injection by slowly adding 0.7 cc. diluent to contents of // ampoule. Gently agitate and allow a few seconds for the contents to dissolve. // DOSE – A single injection of 0.5 cc. of solution prepared as above, administered // subcutaneously into the upper arm; or subcutaneously or intramuscularly into the // upper, outer quadrant of the buttocks. For coadministration of gamma globulin, // see package insert. // Administration to infants under nine months of age is not recommended. // See package insert for contraindications and precautions. // Expiration Date: [printed] // Oct. 15, 1969 [stamped] // Lot No. [printed] // PD804B [stamped] // Stock 4-49-1-70 // Distributed by // PARKE, DAVIS & CO. DETROIT, MICH., U.S.A."; front: "Each dose contains not less than 1000 TCid50 ["50" subscr.] of measles virus vaccine as compared // to U.S. NIH measles virus reference standard, not more than 33 mcg. dihydrostrep- // tomycin sulfate and 17 units of polymyxin B sulfate. // CUT ON DOTTED LINE // Store at temperature between 2° and 8° C (35.6° and 46.4° F.). // Storage at freezing temperature not required. // Protect vaccine from prolonged exposure to direct sunlight."; back: "Manufactured by // PHILIPS ROXANE, INC. ST JOSEPH, MO., U.S.A. // U.S. Licence 376. Canadian Licence 127"; (b-e) "1 DOSE Bio. 49 // MEASLES VIRUS VACCINE, // LIVE, ATTENUATED // 1000 TCID50 ["50" subscr.] // See insert. // US. Licence 376 // Mfd. by Philips Roxane, Inc. // St. Joseph, Mo., U.S.A. // Dist. by Parke, Davis & Co. // Detroit, Mich., U.S.A.// LOT PD 804B // Exp. )ct. 15-69 [stamped]"; (f) same printed text as (b-e) followed by "LOT PD619-1 // Exp. Aug. 24-68"; (g) "4.5 CC. // DILUENT FOR MEASLES VIRUS // VACCINE, LIVE, ATTENUATED // Mfd. by Philips Roxane, Inc. // St. Joseph, Mo., U.S.A. // Dist. by Parke, Davis & Co. // Detroit, Mich., U.S.A. // Contains 0.05% methylparaben and // 0.005% propylpara- // ben as preservatives. // LOT 7404D [stamped]"
Permanent Location
Storage Room 0010
0010-A3-5 Row B
Temporary Location
On exhibit at City of Ottawa - Public Health L-2016-3 14 Mar 2016 – 31 Dec 2018
Condition Remarks
Label is yellowing, dirty; some dents in styrofoam; labels on ampoules and vial are yellowing.
Copy Type
Original
Exhibit History
May 24 - Sept. 13, 2001: Agnes Etherington Art Centre Museopathy exhibit
Images
Less detail

animal vaccine injector kit

https://mhc.andornot.com/en/permalink/artifact4068
Dates
1931
circa 1931
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
Accession Number
000001275 a-g
Description
Kit consists of (a) a cardboard box and (b) its lid, (c) the injector syringe: a metal barrel with a needle tip; inside the barrel is a spring-loaded plunger to push the pellet through the needle; spring is coiled and sprung by means of a metal knob on the side of the barrel that moves through a ho…
  1 image  
Accession Number
000001275 a-g
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Other
Vaccination
MeSH Heading
Vaccines
Veterinary Drugs
Syringes
Injections -- instrumentation
Vaccination
MM= Drugs -- vaccines -- container
MM= Injections -- accessories
MM= Drug Packaging -- container -- vial
Description
Kit consists of (a) a cardboard box and (b) its lid, (c) the injector syringe: a metal barrel with a needle tip; inside the barrel is a spring-loaded plunger to push the pellet through the needle; spring is coiled and sprung by means of a metal knob on the side of the barrel that moves through a hole cut in the barrel for that purpose; (d) a metal tube that serves as a cap for the needle, (e) a cylindrical plastic vial, stopped with a cork and wrapped in a paper label with one pellet inside, (f) a paper notice, and (g) an instruction leaflet; box is lined with crumpled tissue paper that has not been given an accession number.
Number Of Parts
7
Part Names
a - box bottom - Size: Length 18.0 cm x Width 3.4 cm x Depth 3.3 cm
b - box lid - Size: Length 18.3 cm x Width 3.8 cm x Depth 3.4 cm
c - syringe - Size: Length 14.8 cm x Diam. 2.1 cm
d - cap - Size: Length 4.1 cm x Diam. 0.6 cm
e - vial - Size: Length 2.2 cm x Diam. 0.6 cm
f - notice - Size: Length 7.7 cm x Width 4.1 cm
g - leaflet (unfolded) - Size: Length 17.3 cm x Width 10.6 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co., Ltd.
Site Made (City)
Walkerville
Site Made (State)
Ontario
Site Made (Country)
Canada
Dates
1931
circa 1931
Date Remarks
Based on lot number
Material
cork: brown
paper: white; beige; black; blue
metal: silver
cardboard: brown; grey
plastic: translucent yellow
Inscriptions
(a) Bottom: "MADE IN U.S.A. [stamped]"; (b) left side: "Animal Vaccine // INJECTOR // Syringe No. 17 // C779206 [stamped] // PARKE DAVIS & CO [engraved]"; (e) "BLACKLEG VACCINE // SINGLE Dose: 1 Oid. // Use // before June 1935 // C691502 // PARKE, DAVIS & Co."; (f) "NOTICE // When the syringe was packed it was examined and // found to be in perfect order, and should reach you // in that condition. We cannot, therefore, hold our- // selves resposible for any injury which may occur // to the instrument after its receipt. We do not // accept any syringe for credit or exchange after it // has been used. // PARKE, DAVIS & CO., Ltd."; (g) "How to Use the Animal // Vaccine Injector // [text follows] // TO PREVENT THE SPREAD OF INFECTION // [text follws] // PARKE, DAVIS & CO., LTD. // WALKERVILLE, ONTARIO"
Permanent Location
Storage Room 0010
0010-A3-4 Row D
Condition Remarks
Water mark on box bottom and bottom edge of box top; corners of box top scuffed, dented; no corrosion on syringe or cap; paper label on vial yellowing; vial lip broken, with a piece missing; cork still fits securely; paper leaflets are yellowed
Copy Type
Original
Reference Types
Document
Reference Comments
Parke-Davis Lot Numbering System
Images
Less detail
Dates
1975
circa 1975
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001281 a-c
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
  1 image  
Accession Number
000001281 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Company
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1975
circa 1975
Date Remarks
Based on expiry date
Material
glass: clear
paper: white; blue; black
cardboard: white; blue
plastic: blue
metal: silver
rubber: pink
Inscriptions
(a) Front: "5 ML. Bio. 1568 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1973-74 season. // Stock 4-1568-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 1000 CCA units per human dose (0.5 // ml.) in the recommended ratio of 700 CCA units of the A // influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injections // of 0.5 ml. each, given at least two months apart. See // package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propogated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1568 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] Feb. 1, 1975 // 903033B [stamped]"; (b) front: "C // 5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains no less than 1000 CCA units per human dose // (0.5 ml.) in the recommended ratio of 700 CCA units of the A influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – Two // intramuscular injections of 0.5 // ml. each, given at least two months apart. See package // inssert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp Date and Lot [printed] // Feb. 1, 1975 // 903033B [stamped]"; bottom: "W // 83 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "C // FLUOGEN® // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 877800 C-PO // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from DESCRIPTION] // INDICATIONS // [text follows] // 121 877800 2 C - PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from INDICATIONS] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 121 877800 3 C-PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 877800 //Parke, Davis & Co. // Detroit, Mi 48232 USA C-PD // A // Issued Aprile 1973 [French translation appears alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Condition Remarks
Box somewhat dirty, dented; no apparent problems wtih vial or leaflet
Copy Type
Original
Reference Types
Other
JPG
Reference Comments
See also 000.001.282; CD #8
Images
Less detail
Dates
1974
circa 1974
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001282 a-c
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
  1 image  
Accession Number
000001282 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines
Vaccination
Influenza
MM= Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Cylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Company
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1974
circa 1974
Date Remarks
Based on expiry date
Material
glass: clear
paper: white; blue; black
cardboard: white; blue
plastic: blue
metal: silver
rubber: pink
Inscriptions
(a) Front: "5 ML. Bio. 1568 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1973-74 season. // Stock 4-1568-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 1000 CCA units per human dose (0.5 // ml.) in the recommended ratio of 700 CCA units of the A // influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injections // of 0.5 ml. each, given at least two months apart. See // package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propogated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1568 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] Nov. 15, 1974 // 903028C [stamped]"; (b) front: "C // 5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains no less than 1000 CCA units per human dose // (0.5 ml.) in the recommended ratio of 700 CCA units of the A influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – Two // intramuscular injections of 0.5 // ml. each, given at least two months apart. See package // inssert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp Date and Lot [printed] // Nov. 15, 1974 // 903028C [stamped]"; bottom: "W // 91 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "C // FLUOGEN® // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 877800 C-PO // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from DESCRIPTION] // INDICATIONS // [text follows] // 121 877800 2 C - PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from INDICATIONS] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 121 877800 3 C-PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 877800 //Parke, Davis & Co. // Detroit, Mi 48232 USA C-PD // A // Issued Aprile 1973 [French translation appears alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Condition Remarks
Box somewhat dirty, dented; no apparent problems wtih vial or leaflet
Copy Type
Original
Reference Types
Other
JPG
Reference Comments
See also 000.001.281; CD #8
Images
Less detail

Influenza Virus Vaccine

https://mhc.andornot.com/en/permalink/artifact4076
Dates
1969
circa 1969
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001283 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over vial neck and lip; vial is in a cardboard box (a) with a paper leaflet (c); there is a square white sticker on left side of box
  1 image  
Accession Number
000001283 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Influenza
Vaccination
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded over vial neck and lip; vial is in a cardboard box (a) with a paper leaflet (c); there is a square white sticker on left side of box
Number Of Parts
3
Part Names
a - box - Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Length 5.2 cm x Diam. 2.6 cm
c - leaflet (unfolded) - Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis.
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1969
circa 1969
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; red; blue; black
cardboard: white; blue; red; black
rubber: pink
glass: clear
Inscriptions
(a) Front: "10 CC. Bio. 844 // INFLUENZA VIRUS VACCINE, // BIVALENT // C // Contains: A2 //Japan/170/62, A2 // Taiwan/1/64 // and B/Massachusetts/3/66 strains. // BIVALENT // Stock 4-844-1-70 // PARKE-DAVIS"; bottom: "Standardized according to the U.S. Public Health // Service requirements for the 1968-69 season. // Contains 0.01% thymersal (mercury derivative). // Store at temperature between 2° and 8° C. // (35.6° and 46.4° F.). // FREEZING DESTROYS POTENCY"; back: "Prepared from the refined extra-embryonic fluid of // the chick embryo, killed by ultraviolet irradiation // and formalin, and absorbed on aluminum phosphate. // U.S. Licence No. 1 // Canadian Licence no. 1"; top: "SHAKE WELL BEFORE USING // USUAL ADULT DOSE – Two intramuscular injec- // tions of 1 cc. each, given at least two months // apart. See package insert. // Parke, Davis & Company // Detroit, Michigan, U.S.A. 48232"; right side: "10 CC. Bio. 844 // INFLUENZA // VIRUS VACCINE, // BIVALENT // Parke, Davis & Co. // Expiration Date and Lot // NOV 15, 1969 // 985259B"; left side: "10 CC. Bio. 844 // INFLUENZA // VIRUS VACCINE, // B1 [illeg.] // Pa [illeg.] Co. // S [illeg.]"; (b) front: "C 10 CC. Bio. 844 // INFLUENZA VIRUS VACCINE, // BIVALENT // Contains: A2 // Japan/170/62, A2 /Taiwan/64 // and B/Massachusetts/3/66 strains. // Standardized according to the U.S. Public // Health Service requirements for the // 1968-69 season. // BIVALENT // PARKE, DAVIS & CO. DETROIT, Mich., U.S.A."; back: "USUAL ADULT DOSE // Two intramuscular in- // jections of 1 cc. each, // given at least two months // apart. See package // insert. // SHAKE WELL // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Expiration date and Lot // Nov. 15, 1969 // 985259B "; bottom: "NT I // K // 10 // U.S.A."; (c) "C // INFLUENZA VIRUS VACCINE // BIVALENT POLYVALENT // PARKE-DAVIS // Beginning with the 1967-68 season, Influenza Virus // Vaccine is supplied in two formulas: // [text follows] // INDICATIONS // [text follows] // HB // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 2 // HB // [text continues from Adverse Reactions] // ADMINISTRATION AND DOSAGE // [text follows] // 3 // HB // [text continues from Administration] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // PARKE, DAVIS [logo, see sketch on accession sheet] & COMPANY // 121 856750 // K - 97 - A DETROIT, MICHIGAN, U.S.A. HB // Issued Mar. 1968 [French translation accompanies English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Temporary Location
On loan to Museum of Health Care Education Department for Seniors’ Learning Program 22 Aug 2016.
Condition Remarks
Box somewhat yellowed, dented, dirty; leaflet mottled with a yellow stain throughout; no apparent problems with vial
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail

Influenza Virus Vaccine vial

https://mhc.andornot.com/en/permalink/artifact4077
Dates
1981
circa 1981
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
Accession Number
000001284 a-c
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lipwith a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (…
  1 image  
Accession Number
000001284 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseases
Vaccination
MeSH Heading
Viral Vaccines -- therapeutic use
Influenza
Vaccination
Drugs -- vaccines -- container
MM= Drug Packaging -- container -- vial
Description
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lipwith a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1981
circa 1981
Date Remarks
Based on expiry date
Material
metal: silver
paper: white; blue; black
cardboard: white; blue; black
rubber: pink
glass: clear
plastic: blue
Inscriptions
(a) Front: "DIN 248991 Stock 4-4079-63-70 // INFLUENZA VIRUS VACCINE, // TRIVALENT, TYPES A AND B // FLUOGEN® Subvirion Vaccine // Dose – Persons 27 years and older, a single injection of 0.5 ml; // persons 3 years through 26 years, 2 injections of 0.5 ml, 4 or // more weeks apart; persons 6 months through 35 months, 2 // injections of 0.25 ml, 4 or more weeks apart. Inject // intramuscularly. See package insert. // 5 ml PARKE-DAVIS"; bottom: "Standardized according to 1979-80 NACI and US PHS requirements. // Contains no less than 21 micrograms of HA antigen content per // 0.5 ml dose in the recommended ratio of 7µg of HA of the A // influenza virus component representative of A/Brazil/78 (H1N1), 7 // µg of HA of the A influenza virus component representative of // A/Texas/1/77 (H3N2), and 7µg of HA of the B influenza virus component representative of B/Hong Kong/5/72. The vaccine is of chick embryo origin. // Polysorbate 80, USP, added during manufacture. // Preservative: 0.01% thimer- // osal (mercury derivative). //Store at temperature between // 2° and 8° C (36° and 46° F). // Freezing destroys potency. // Exp date and lot [printed] // FEB. 5, 1981 // YH601 [stamped]"; back: front repeated in French; top: bottom repeated in French up to and including "Freezing destroys potency"] // Permis US n°1 Permis can. n°1 // Parke, Davis & Co/Detroit, Mi 48232 USA"; right side: "5 ml // FLUOGEN // U.S. Lic. No. 1 Can. Lic. No. 1 // PARKE-DAVIS"; left side: "5 ml // FLUOGEN // Stock 4-4079-63-70 // PARKE-DAVIS // Printed in USA // 120 // 457217"; (b) front: "DIN 248991 C // INFLUENZA VIRUS VACCINE, TRIVALENT // TYPES A AND B FLUOGEN® Subvirion // Vaccine // [contents as listed on box front] // The vaccine is of chick embryo origin. // 5 ml PARKE-DAVIS"; back: "LOT YH607 [stamped] // Dose – See package insert. // Standardized according to // the NACI and the US PHS // requirements for the // 1979-80 season. // Stock 4-4079-63-70 // U.S. Lic. No. 1 Can Lic. No. 1 [printed] // EXP FEB. 5, 1981 [stamped] // Parke, Davis & Co // Detroit, Mi 48232 USA // 02 4079 70 1 [printed]"; bottom: "W // 79 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "FLUOGEN® // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // Subvirion Vaccine/Immunizing Antigen, Ether Extracted // DESCRIPTION // [text follows] // ACTION // [text follows] // PARKE-DAVIS // 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Action] // INDICATIONS // 2 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // WARNING // [text follows] // PRECAUTIONS // [text follows] // USAGE IN PREGNANCY // [text follows] // ADVERSE REACTIONS // 3 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Adverse Reactions] // DOSAGE AND ADMINISTRATION // [text follows] // STORAGE // [text follows] // PACKAGE INFORMATION // [text follows] // Unpublished data available upon request. // Issued June 1979 // Parke, Davis & Co., Detroit, Mi 48232 USA 121 887150/C-KF // [French translation accompanies English text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box somewhat yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Reference Types
JPG
Reference Comments
CD #8
Images
Less detail

22 records – page 1 of 3.